Načítá se...
Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene
INTRODUCTION: Raloxifene, a non-steroidal selective estrogen receptor modulator (SERM), offers a new dimension for the treatment and prevention of osteoporosis and risk reduction of invasive breast cancer in postmenopausal populations at high risk. Both osteoporosis and breast cancer are important p...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3085345/ https://ncbi.nlm.nih.gov/pubmed/21294695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14656566.2011.557360 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|